Skin-derived tumor specific T cells predict clinical outcome in dendritic cell vaccination studies in both stage III and IV melanoma patients

Por Aarntzen, EHJG, Lesterhuis, W J, Van Rossum, M, Adema, G J, Figdor, C F, Punt, CJA, De Vries, IJM
Publicado em 2010